Racemic Ephedrine Hydrochloride,see
Racephedrine Hydrochloride
Racemic Menthol,see Racementhol
Racephedrine Hydrochloride,II-725
Raclopride ([
11
C]Methoxy) Injection,
IV-701
Raclopride Tartrate,V-A112
Radian, Deļ¬nition of,I-32,II-32,
III-32,IV-32,V-32
Radionuclides, Table of Physical
Characteristics (5.7.),IV-656
Radiopharmaceutical Preparations,
IV-651
Raft strength,see Appendix XVII F2
Raloxifene Hydrochloride,II-726
Raman Spectrometry,V-184
Ramipril,II-727,V-S122
Ramipril Capsules,III-1050
Ramipril Tablets,III-1051
(1R)-(ā)-Ammonium
10-Camphorsulfonate,V-A26
(1R)-(ā)-Ammonium
10-Camphorsulphonate,see (1R)-(ā)-
Ammonium 10-Camphorsulfonate
Range,V-675
Ranitidine Hydrochloride,II-730,
V-S122
Ranitidine Injection,III-1053
Ranitidine Oral Solution,III-1054
Ranitidine Tablets,III-1055
Ranitidine Tablets, Effervescent,
III-1056
Rapeseed Oil,V-A112
Rapeseed Oil, Reļ¬ned,II-732
Ratanhia,V-609
Reaction of Solution and Colour of
Certain Indicators,V-252
Reagents,I
-24,II-24,III-24,IV-24,
V-24
Reagents, Descriptions of,I-7,II-7,
III-7,IV-7,V-7
Recently Prepared, Deļ¬nition of,I-10,
II-10,III-10,IV-10,V-10
Recombinant DNA Technology,
Products of,II-732
Recommendations on Dissolution
Testing,V-358
Recrystallised Imidazole,V-A74
Recrystallised Iodine Pentoxide,V-A75
Rectal Capsules,III-69
Rectal Foams,III-70
Rectal Preparations,III-68
Rectal Preparations, Semi-solid,III-70
Rectal Solutions, Emulsions and
Suspensions,III-69
Rectiļ¬ed Spirit,I-900
Red Cinchona Bark,see Cinchona Bark
Red Litmus Paper,V-A81
Red Poppy Petals,IV-329
Redox Indicators,V-789
Redox Titrations,V-788
Reducing Mixture,V-A112
Reference Materials,V-A160
Reference Materials and Spectra,I-12,
II-12,III-12,IV-12,V-12
Reference Materials, Chemical and
Biological,
see Reference Materials
Reference Preparation, International,
I-14,II-14,III-14,IV-14,V-14
Reference Spectra,I-12,II-12,III-12,
IV-12,V-12
Reference Spectra, Concordance of,
I-12,II-12,III-12,IV-12,V-12
Reference Spectra, Preparation of
Infrared,V-S2
Reference Standards,I-29,II-29,III-29,
IV-29,V-757,V-29
Reference Substances and Reference
Preparations,I-15,II-15,III-15,
IV-15,V-15
Reference Substances (BP),
Supplementary Information,V-673
References to regulatory documents,
I-23,II-23,III-23,IV-23,V-23
Reļ¬ned Almond Oil,I-102
Reļ¬ned and Quantiļ¬ed Ginkgo Dry
Extract,IV-201
Reļ¬ned and Standardised Capsicum
Oleoresin,IV-122
Reļ¬ned and Standardised Fresh Bilberry
Fruit Dry Extract,IV-101
Reļ¬ned and Standardised Milk Thistle
Dry Extract,IV-
279
Reļ¬ned Arachis Oilsee Arachis Oil
Reļ¬ned Borage Oil,I-305
Reļ¬ned Borage (Starļ¬ower) Oil, ,see
Reļ¬ned Borage Oil
Reļ¬ned Castor Oil,I-429
Reļ¬ned Evening Primrose Oil,I-930
Reļ¬ned Maize Oil,II-179
Reļ¬ned Olive Oil,II-427
Reļ¬ned Rapeseed Oil,II-732
Reļ¬ned Safļ¬ower Oil,II-778
Reļ¬ned Sesame Oil,II-799
Reļ¬ned Soya Oil,II-894
Reļ¬ned Soya-bean Oil,see Reļ¬ned Soya
Oil
Reļ¬ned Starļ¬ower Oil,see Reļ¬ned Borage
Oil
Reļ¬ned Sunļ¬ower Oil,II-965
Reļ¬ned Wheat-germ Oil,II-1184
Refractive Index, Determination of,
V-244
regulatory documents,References to,
I-23,II-23,III-23,IV-23,V-23
Rehydration Salts, Oral,III-921
Reichsteinās Substance S,V-A112
Related substances in phenothiazines,
V-197
Related Substances, Tests for,V-637
Relative Atomic and Molecular Masses,
I-25,II-25,III-25,IV-25,V-25
Relative Density,V-245
Relative Density, Determination of,
V-245
Release Assay,
V-657
Repaglinide,II-734
Repeatability,V-674
Reproducibility,V-675
Requirements, Pharmacopoeial,I-xxv
Reserpine,II-736,V-A112
Residual Ethylene Oxide and Dioxan,
V-293
Residual Pertussis Toxin and
Irreversibility of Pertussis Toxoid,
V-450
Residual Solvents,V-289,V-639,V-678
Residue on Evaporation of Essential Oils,
V-321
Resin for Reversed-phase Ion
Chromatography,V-A112
Resistance to Crushing of Tablets,V-513
Resolution factor, Liquid
Chromatography,V-204
Resorcinol,II-737,V-A112
Resorcinol Reagent,V-A112
Restharrow Root,IV-334
Resveratrol,V-A112
Retinol Concentrate (Oily Form),
Synthetic,II-738
Retinol Concentrate (Powder Form),
Synthetic,II-739
Retinol Concentrate Solubilisate/
Emulsion, Synthetic,II-740
L-Rhamnose,V-A112
Rhamnose,see
L-Rhamnose
Rhaponticin,V-A112
Rhatany Root,IV-335
Rhatany Tincture,IV-336
Rheum Palmatum,V-609
Rhodamine 6 G,V-A112
Rhodamine B,V-A112
Rhubarb,IV-337
Rhubarb Tincture, Compound,IV-338
Rhus Toxicodendron for Homoeopathic
Preparations,see Toxicodendron
Quercifolium for Homoeopathic
Preparations
Ribavirin,II-742,V-S123
Ribavirin for Nebulisation,see Ribavirin
Powder for Nebuliser Solution
Ribavirin Nebuliser Solution,see
Ribavirin Powder for Nebuliser Solution
Ribavirin Powder for Nebuliser Solution,
III-1057
Riboļ¬avin,II-743
Riboļ¬avin Sodium Phosphate,II-745
Ribose in Polysaccharide Vaccines,
V-468,V-A112
Rice Starch,II-915
Ricinoleic Acid,V-A112
Rifabutin,II-747
Rifampicin,II-748,V-S123
Rifampicin Capsules,III-1058
Rifampicin Oral Suspension,III-1059
Rifamycin Sodium,II-750
Rifaximin,II-751
Rilmenidine Dihydrogen Phosphate,
II-
753
Ringer-Lactate Solution for Injection,
III-1102
Risedronate Sodium 2.5-Hydrate,II-754
Risperidone,II-756
Risperidone Oral Solution,III-1060
Risperidone Tablets,III-1061
Risperidone Tablets, Dispersible,
III-1063
Ritodrine Hydrochloride,II-758,V-S123
Ritodrine Injection,III-1065
Ritodrine Tablets,III-1066
Ritonavir,II-759
Rivastigmine,II-763
Rivastigmine Hydrogen Tartrate,II-764
Rizatriptan Benzoate,II-766,V-S124
(R)-(þ)-a-Methylbenzyl IsoCyanate,
V-A87
(15R)-15-Methylprostaglandin F
2a,
V-A90
Robustness,V-675
page numbers inbold typerelate to monograph titles Index V-A851